These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 315269)

  • 1. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
    Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
    Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to chemotherapeutic and immunomodulating agents of two mouse lymphomas and of a macrophage tumor.
    Tarnowski GS; Ralph P; Stock CC
    Cancer Res; 1979 Oct; 39(10):3964-7. PubMed ID: 476634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.
    Ho RL; Maccubbin DL; Ujházy P; Zaleskis G; Eppolito C; Mihich E; Ehrke MJ
    Oncol Res; 1993; 5(9):363-72. PubMed ID: 8038457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the immunological mechanism of anti-tumor effects of 5-FU by establishing EL4 tumor-bearing mouse models].
    Li ML; Li CG; Shu XH; Li MX; Jia YJ; Qin ZH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1010-3. PubMed ID: 17988579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
    Nagarkatti M; Toney DM; Nagarkatti PS
    Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lymphocyte migration into syngeneic tumors.
    Elboim CM; Reinisch CL; Schlossman SF
    J Immunol; 1977 Mar; 118(3):1042-8. PubMed ID: 300384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
    Ghayur T; Seemayer TA; Lapp WS
    Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL; Mace KF; Ehrke MJ; Mihich E
    Cancer Res; 1989 Aug; 49(15):4216-24. PubMed ID: 2525950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine therapy of established tumors in the absence of autoimmunity.
    Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
    Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor colony formation by Friend virus-infected cells in immunosuppressed mice.
    Axeirad AA; Cinader B; Koh SW; van der Gaag HC
    Cancer Res; 1976 Jan; 36(1):28-32. PubMed ID: 1248007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.